Value & Access

Many of the 84 million Americans living with cardiovascular disease face barriers to getting the treatment that is right for them. The National Forum is engaging diverse stakeholders in a transformative, consensus-building initiative to overcome the barriers. Together, we are accelerating collaboration, breaking the stalemate and improving access to evidence-based care.

What do Value & Access Really Mean?

This National Forum landscape report reveals how patients, providers, payers, public health and industry view the value of therapies and what access means to them.

Consensus Goal

Enhance health and well-being by supporting people’s access to evidence-based care that is appropriate for them by:

  • Identifying evidence-based strategies for determining appropriateness of care
  • Supporting the implementation of evidence-based care that aligns incentives for patients, providers, payers, other stakeholders

The Steering Committee will share research, facts, best practices and policies to advance the consensus goal through its Action Agenda.

Action Agenda

Understand Best Practices on Payer/Purchaser Coverage Decisions

Highlight a way for all stakeholders to communicate, share evidence, best practices & identify areas for improvement


Patient Engagement Strategies

Identify effective and scalable shared-decision making tools and models

Patient Adherence

Identify and endorse or highlight models, research, tools and resources

Shift Spend From Low- to High-Value Care

Identify & support effective leverage points already underway that meet stakeholder needs

Value & Access Clearinghouse

Stakeholder Resources

Steering Committee Members

The steering committee includes a broad range of experts representing public health, patients, providers, payers, and pharma/biotech.

Jennifer Robinson, MD, MPH

Title Steering Committee Chair

Positions held
  • Professor Departments of Epidemiology & Medicine,
  • Director Prevention Intervention Center, University of Iowa


Catherine Davis Ahmed, MBA

Positions held
  • Director of Outreach, FH Foundation

Madeleine Konig, MPH

Positions held
  • Senior Policy Analyst, American Heart Association (AHA)

Norm Linsky

Positions held
  • Executive Director, Mended Hearts

Mary McGowan

Positions held
  • CEO, WomenHeart

Sara Traigle van Geertruyden

Positions held
  • Executive Director, Partnership to Improve Patient Care


Jim Ballenger, MBA

Positions held
  • Principal, BallengeRx Consulting

Michael Cropp, MD, MBA

Positions held
  • President and Chief Executive Officer, Independent Health

Lorena de Leon

Positions held
  • National Director, Cross Optum Programs, Optum Life Sciences

Tripp Jennings, Jr, MD, FACEP

Positions held
  • Innovation Officer, VP, Blue Cross Blue Shield of South Carolina

Michael Thompson, FSA

Positions held
  • President and CEO, National Alliance of Healthcare Purchaser Coalitions



Positions held
  • Immediate Past President, American Society for Preventive Cardiology (ASPC)

Benjamin M. Bluml, RPh

Positions held
  • Senior Vice President Research and Innovation, American Pharmacists Association (APhA) Foundation

Brian Hart, JD

Positions held
  • Executive Director, National Lipid Association

Sue Koob, MPA

Positions held
  • CEO, Preventive Cardiovascular Nurses Association (PCNA)

Karyn Lockshine, CAE

Positions held
  • Executive Director, American Association of Heart Failure Nurses

Cassandra McCullough, MBA

Positions held
  • CEO/Executive Director, Association of Black Cardiologists

J. Brendan Mullen

Positions held
  • Executive Vice President, American College of Cardiology

Joyce Ross, MSN, CRNP, CS, CLS, FNLA

Positions held
  • President 2016-2017, National Lipid Association

Public Health

A. Mark Fendrick, MD

Positions held
  • Director Center for Value-Based Insurance Design (V-BID), University of Michigan

Melita Jordan, CNM MSN, APRN C, CPM

Positions held
  • Senior Executive Service Director Chronic Disease Prevention & Control Services Unit, New Jersey Department of Health and Senior Service

Marcus Plescia, MD, MPH

Positions held
  • Chief Medical Officer , Association of State and Territorial Health Officials (ASTHO)

Fortunato “Fred” Senatore, MD, PhD, FACC 

Positions held
  • Medical Officer, Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, Food and Drug Administration


Mary Jo Carden, JD

Positions held
  • VP of Government & Pharmacy Affairs, Academy of Managed Care Pharmacy (AMCP)

Kimberly Westrich, MA

Positions held
  • Vice President for Health Services Research, National Pharmaceutical Council (NPC)

Funding for this initiative provided by: